BIOSYNTHESIS AND CHARACTERIZATION OF (S) AND (R)-3-HYDROXY-3-METHYLGLUTARYL COENZYME-A

被引:23
作者
BISCHOFF, KM [1 ]
RODWELL, VW [1 ]
机构
[1] PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907
来源
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 1992年 / 48卷 / 02期
关键词
D O I
10.1016/0885-4505(92)90060-C
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
(S)-3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA), the physiologic substrate of HMG-CoA reductase and of HMG-CoA lyase, is available commercially only as (R,S)-HMG-CoA, a mixture of diastereomers. To provide (S)-HMG-CoA for our continuing investigation of HMG-CoA reductase, we used homogeneous, overexpressed Pseudomonas mevalonii HMG-CoA reductase (EC 1.1.1.88) and an NAD+-regenerating system to convert (R)-mevalonate to (S)-HMG-CoA with an overall yield in excess of 50%. We also used P. mevalonii HMG-CoA lyase (EC 4.1.3.4) to prepare (R)-HMG-CoA from (R,S)-HMG-CoA. Each diastereomer was then isolated by ion-exchange chromatography. Large-scale preparations provide for economical production of (S)-HMG-CoA, particularly when recovered coenzyme A is recycled. (S)-HMG-CoA was evaluated as a substrate, and (R)-HMG-CoA as an inhibitor, for the P. mevalonii enzymes HMG-CoA reductase and HMG-CoA lyase, and for Syrian hamster HMG-CoA reductase (EC 1.1.1.34). For both HMG-CoA reductases, (R)-HMG-CoA inhibited competitively with respect to (S)-HMG-CoA. The ratio Ki Km was 0.7 ± 0.1 and 0.6 ± 0.2 for the bacterial and hamster enzymes, respectively. By contrast, (R)-HMG-CoA did not inhibit P. mevalonii HMG-CoA lyase. © 1992.
引用
收藏
页码:149 / 158
页数:10
相关论文
共 18 条
  • [1] ASSAY OF SHORT-CHAIN ACYL COENZYME-A INTERMEDIATES IN TISSUE-EXTRACTS BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY
    CORKEY, BE
    BRANDT, M
    WILLIAMS, RJ
    WILLIAMSON, JR
    [J]. ANALYTICAL BIOCHEMISTRY, 1981, 118 (01) : 30 - 41
  • [2] DARNAY BG, 1992, J BIOL CHEM, V267, P15064
  • [3] ABSOLUTE KONFIGURATION DES MEVALOLACTONS
    EBERLE, M
    ARIGONI, D
    [J]. HELVETICA CHIMICA ACTA, 1960, 43 (06) : 1508 - 1513
  • [4] CHEMISTRY, BIOCHEMISTRY, AND PHARMACOLOGY OF HMG-COA REDUCTASE INHIBITORS
    ENDO, A
    [J]. KLINISCHE WOCHENSCHRIFT, 1988, 66 (10): : 421 - 427
  • [5] GOLDFARB S, 1971, J LIPID RES, V12, P512
  • [6] GRUNERT RR, 1951, ARCH BIOCHEM, V30, P217
  • [7] JORDANSTARCK TC, 1989, J BIOL CHEM, V264, P17919
  • [8] JORDANSTARCK TC, 1989, J BIOL CHEM, V264, P17913
  • [9] PASTUSZYN A, 1983, J LIPID RES, V24, P1411
  • [10] PLEMENITAS A, 1990, J BIOL CHEM, V265, P17012